Glucocorticoids: exemplars of multi-tasking

Department of Cellular and Molecular Neuroscience, Division of Neuroscience and Mental Health, Imperial College London, Hammersmith W12 0NN.
British Journal of Pharmacology (Impact Factor: 4.99). 02/2006; 147 Suppl 1(S1):S258-68. DOI: 10.1038/sj.bjp.0706456
Source: PubMed

ABSTRACT Well over 80 years ago Philip Smith described the beneficial clinical effects of adrenocortical extracts in animal models of adrenal insufficiency. In the ensuing years, scientists across the globe have sought to understand the mechanisms by which adrenal hormones and their synthetic analogues produce their complex and varied actions. Particular attention has focused on the glucocorticoids, partly because they have a vital place in the treatment of inflammatory and autoimmune disorders but also because dysregulation of the secretion and/or activity of endogenous glucocorticoids is increasingly implicated in a number of common disorders that pose a growing clinical burden, such as obesity, type II diabetes, the metabolic syndrome, hypertension and depression. This review considers some of the key advances that have been made in our understanding of the physiology, pathology and pharmacology of the glucocorticoids. Emphasis is placed on the molecular mechanisms of glucocorticoid signalling and the complex mechanisms that regulate the access of steroids in the systemic circulation to their receptors in their various target cells and tissues. In addition, consideration is given to the irreversible 'organisational' actions of glucocorticoids in perinatal life and to the potential role of the steroids in the aetiology of disease.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: In humans and zebrafish, two glucocorticoid receptor splice variants exist: the canonical GR α-isoform (GRα), and the GR β-isoform (GRβ). In the present study we have used the zebrafish model system in order to reveal genes affected by each of these two receptor isoforms. By injecting zebrafish embryos with different splice-blocking morpholinos, we could knock down both GR isoforms or could target the alternative splicing of the GR pre-mRNA in favor of the GR β-isoform. In addition, specific GRβ overexpression was achieved by injecting mRNA. Embryos were treated with the synthetic glucocorticoid dexamethasone and transcriptome analysis was performed. Two distinct gene clusters were found that are regulated by GRα. One that was regulated by GRα under basal conditions (presence of endogenous cortisol only), and one that is regulated upon increased activation of GRα (using a pharmacological dose of dexamathasone). GRβ may act as a dominant-negative inhibitor of GRα when GRβ is overexpressed and the GRα expression level is knocked down simultaneously, but without GRα knockdown no evidence for this activity was found. In addition, the data indicate regulation of gene transcription through other mechanisms of action by GRβ. We also investigated the concentrations of several metabolites using NMR spectroscopy. We found that dexamethasone treatment and knockdown of GRα together with overexpression of GRβ had opposite effects on glucose, amino acid and fatty acid levels. Thus, we have shed new light on the molecular mechanisms of glucocorticoid-induced effects on metabolism, which are known to increase the risk of obesity, hyperglycemia and diabetes.
    Endocrinology 03/2015; 156(5):en20141941. DOI:10.1210/en.2014-1941 · 4.64 Impact Factor
  • Source
    Neuro-immune interaction in the adult central nervous system, 01/2013: chapter 1: pages 1-22;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hypothalamo-pituitary-adrenocortical dysfunction contributes to morbidity and mortality in a high proportion of patients with sepsis. Here, we provide new insights into the underlying adrenal pathology. Using a murine model of endotoxemia (LPS injection), we demonstrate that adrenal insufficiency is triggered early in the disease. LPS induced a local inflammatory response in the adrenal gland within 4 hours of administration, coupled with increased expression of mRNAs for annexin A1 (AnxA1) and the formyl peptide receptors [(Fprs) 1, 2, and 3], a loss of lipid droplets in cortical cells (index of availability of cholesterol, the substrate for steroidogenesis), and a failure to mount a steroidogenic response to ACTH. Deletion of AnxA1 or Fpr2/3 in mice prevented lipid droplet loss, but not leukocyte infiltration. LPS increased adrenal myeloid differentiation primary response gene 88 and TLR2 mRNA expression, but not lymphocyte antigen 96 or TLR4. By contrast, neutrophil depletion prevented leukocyte infiltration and increased AnxA1, Fpr1, and Fpr3 mRNAs but had no impact on lipid droplet loss. Our novel data demonstrate that AnxA1 and Fpr2 have a critical role in the manifestation of adrenal insufficiency in this model, through regulation of cholesterol ester storage, suggesting that pharmacologic interventions targeting the AnxA1/FPR/ALX pathway may provide a new approach for the maintenance of adrenal steroidogenesis in sepsis.-Buss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., Buckingham, J. C. Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex. © FASEB.
    The FASEB Journal 03/2015; DOI:10.1096/fj.14-268375 · 5.48 Impact Factor

Full-text (2 Sources)

Available from
Sep 22, 2014